Clinical trial

MDMA in Borderline Personality Disorder

Yale UniversityRecruitingPhase 2Started Sep 5, 202510 enrolledUnited StatesNCT06683014

Abstract

The purpose of this study is to test the effects of MDMA (3,4-methylenedioxymethamphetamine) on social cognition in adults with Borderline Personality Disorder.

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

MDMA

Keywords

3,4-methylenedioxymethamphetaminesocial cognitionBorderline Personality Disorder

View on registry

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.

Related research

ArticleMDMA

Chemsex drugs: More than ghb, mephedrone and methamphetamine?

Ramos J, Dolengevich H, Romerosa M +1

Europe PMC2021

ArticleMDMA

The effect of methamphetamine and 3,4-methylenedioxymethamphetamine on peripheral endocannabinoid concentrations: a study in healthy adults.

Deutsch A, Haggarty CJ, Petrie GN +4

Europe PMC2026

ArticleMDMA

Aesthetic mediation and lateral agency: Rethinking trauma and drug consumption in 'crisis ordinariness'.

Fomiatti R, Keane H, Nourse G +4

Europe PMC2026